CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...

Horses with genomic edits to make them run faster have been banned from polo, but a zoo of CRISPR-edited animals is gaining ...

The new system developed by Professor Chad Mirkin delivers CRISPR machinery more safely and effectively into cells.

Edits create cells that don’t trigger an immune response, allowing implant recipient to forego immune-suppressing drugs.

Researchers at the Max Delbrück Center have developed a new method to discover how DNA controls genes. Their technique, ...

Can genetic editing help improve the overall health of people living with type 1 diabetes? The results of a recent study ...

Researchers have unveiled a new type of nanostructure that dramatically improves CRISPR delivery. Called lipid nanoparticle ...

It has long been understood that orchard automation is the key for industry’s profitability and sustainability. As part of ...

This little company's scientific breakthrough opened up a whole new sliver of the drug market (although it's still leading ...

CRISPR Therapeutics AG ( NASDAQ: CRSP) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 8:30 AM EDT ...

When scientists discovered how bacteria protect themselves against viral invaders, called phages, in the early 2000s, little ...

CRISPR stock offers bold investment potential and how strategic portfolio management can boost resilience and long-term ...